-
Taxonomy & unit
-
us-gaap: USD/shares
-
Description
-
The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.
-
Summary
-
Context Therapeutics Inc. quarterly/annual Earnings Per Share, Basic history and growth rate from Q3 2020 to Q3 2024.
- Context Therapeutics Inc. Earnings Per Share, Basic for the quarter ending September 30, 2024 was -0.22 USD/shares, a 40.5% increase year-over-year.
- Context Therapeutics Inc. Earnings Per Share, Basic for the twelve months ending September 30, 2024 was -0.91 USD/shares, a 30% increase year-over-year.
- Context Therapeutics Inc. annual Earnings Per Share, Basic for 2023 was -1.5 USD/shares, a 61.3% decline from 2022.
- Context Therapeutics Inc. annual Earnings Per Share, Basic for 2022 was -0.93 USD/shares, a 74.8% increase from 2021.
- Context Therapeutics Inc. annual Earnings Per Share, Basic for 2021 was -3.69 USD/shares, a 220% decline from 2020.
Earnings Per Share, Basic, Trailing 12 Months (USD/shares)
Earnings Per Share, Basic, Quarterly (USD/shares)
Earnings Per Share, Basic, YoY Quarterly Growth (%)